Maxxcare
Mega Lifesciences

ZYDUS CADILA HEALTHCARE

Featured products of Zydus Cadila
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
trastuzumab
Packing/Price
(multi-dose + 20 mL bacteriostatic water for injection (diluent)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by Maxxcare
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
trastuzumab
Packing/Price
(multi-dose + 20 mL bacteriostatic water for injection (diluent)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Marketed by Mega Lifesciences
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
trastuzumab
Packing/Price
(multi-dose + 20 mL bacteriostatic water for injection (diluent)) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in